Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update for the quarter ended 30 September 2018

23 Nov 2018 07:00

RNS Number : 2789I
Seneca Growth Capital VCT PLC
23 November 2018
 

Seneca Growth Capital VCT Plc (the "Company")

Update for the quarter ended 30 September 2018

The Company presents its quarterly update for the period from 1 July 2018 to 30 September 2018.

The Directors have recently reviewed the valuation of its portfolio as at the quarter ended 30 September 2018.

The unaudited net asset value per share ("NAV") of an Ordinary Share as at 30 September 2018 was 60.4p. This is a decrease of 1.9p from the previously published NAV for the period ended 30 June 2018, due to changes in the value of the quoted investments. No changes have been made to the unquoted valuations. The ordinary running costs of the Company (limited by the Cost Cap) have been absorbed by the New "B" Share class as set out in the prospectus for the current offer for subscription for those shares (the "Prospectus").

The unaudited NAV of a New "B" Share as at 30 September 2018 was 99.7p. This is a decrease of 0.3p from the initial offer price of 100p, due to running costs incurred in the quarter. The decrease is limited by the impact of the Cost Cap which restricts the burden of ordinary running costs on the New "B" Share class to 3% of the NAV of the New "B" Shares on an annualised basis ("the Cost Cap").

On 23 August 2018 and 27 September 2018, the Company made two allotments, issuing a total of 3,461,786 New "B" Shares. In accordance with the allotment formula set out in the Prospectus, the offer prices at which the New "B" Shares were issued were in the range of 100p to 105.8p per share.

Following the initial allotment on 23 August 2018, the Company repaid its £200,000 bank loan with RBS and the debenture in relation to the loan has now been released. The payment created an inter share class balance between the Ordinary Shares and the New "B" Shares which will be repaid from the next realisations from the Ordinary Share investments.

James Cowper Kreston, our auditors for the last 8 years, have decided to withdraw from auditing Public Interest Entities for the time being due to the increasing regulatory landscape and associated costs. Unfortunately this includes VCTs. The Board would like to thank them for all their support and constructive feedback during their period in office. The Company has therefore carried out a tender process, and the Board, on the recommendation of the Audit Committee, has agreed to appoint UHY Hacker Young LLP ("UHY") to fill the casual vacancy that has arisen. UHY will audit the Company's 2018 annual results for the year ending 31 December 2018, and shareholders will be asked to reappoint them at next year's AGM for the following year's audit.

The Directors are not aware of any other events or transactions which have taken place between 1 October 2018 and the publication of this statement which have had a material effect on the financial position of the Company.

Furthermore, for the purposes of DTR 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules, the total number of shares in the Company in issue as at close of business on 1 October 2018 was 8,115,376 Ordinary Shares and 3,461,786 New "B" Shares each with a nominal value of 1p each. The Company does not hold any Ordinary Shares nor New "B" Shares in treasury. Therefore, the total number of voting rights in the Company is 11,577,162 (the 'Figure').The Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's shares under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

 

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

Any enquiries regarding the offer for subscription of New "B" Shares should be directed to:

 

John Davies at Seneca Partners Limited on 01942 295 981 or at John.Davies@senecapartners.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDVLLFLVFFLFBB
Date   Source Headline
25th Mar 20227:01 amGNWNAV Update
25th Mar 20227:00 amGNWFinal Results for the Year Ended 31 December 2021
8th Mar 20227:00 amGNWInterim Dividend on B Shares
10th Dec 202111:40 amGNWDirector/PDMR Shareholding
8th Dec 20213:24 pmGNWIssue of Equity and Total Voting Rights
16th Nov 20217:00 amGNWSecond Interim Dividend on B Shares
29th Oct 202111:42 amGNWOffer for Subscription and Publication of Prospectus
28th Oct 20211:06 pmGNWTR-1: Notification of major holdings
21st Oct 20219:01 amGNWNAV Update
16th Sep 202112:16 pmRNSSecond Price Monitoring Extn
16th Sep 202112:14 pmRNSPrice Monitoring Extension
14th Sep 20212:07 pmRNSSecond Price Monitoring Extn
14th Sep 20212:01 pmRNSPrice Monitoring Extension
25th Aug 20214:41 pmRNSSecond Price Monitoring Extn
25th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20214:42 pmRNSSecond Price Monitoring Extn
12th Aug 20214:38 pmRNSPrice Monitoring Extension
26th Jul 20217:00 amGNWHalf-year report
15th Jun 202112:18 pmGNWIssue of Equity and Total Voting Rights
15th Jun 20217:00 amGNWB Share Net Asset Value
3rd Jun 202110:51 amGNWInterim Capital Dividend on Ordinary Shares
20th May 20217:00 amGNWB Share Extension of Offer
28th Apr 202110:52 amGNWIssue of Equity and Total Voting Rights
1st Apr 20215:29 pmGNWDirector/PDMR Shareholding
1st Apr 202111:36 amGNWIssue of Equity and TVR
31st Mar 20217:00 amGNWNet Asset Value(s)
29th Mar 20215:12 pmGNWResult of AGM
4th Mar 20215:26 pmGNWDirector/PDMR Shareholding
2nd Mar 202112:50 pmGNWIssue of Equity and Total Voting Rights
24th Feb 20211:49 pmGNWIssue of Prospectus
23rd Feb 20217:00 amGNWFinal Results and NAV Update
18th Feb 20217:00 amGNWDividend Declaration
10th Dec 20203:57 pmGNWDirector/PDMR Shareholding
9th Dec 20203:49 pmGNWIssue of Equity and Total Voting Rights
5th Nov 20207:00 amGNWDividend Declaration
13th Oct 20204:22 pmGNWOffer for Subscription
5th Oct 20207:00 amGNWSecond Interim Capital Dividend
5th Oct 20207:00 amGNWNAV Update
16th Sep 20207:00 amGNWInvestment Realisations and NAV
21st Aug 202010:55 amGNWChange of Registered Office
30th Jul 20207:00 amGNWHalf-year report
10th Jul 202011:43 amGNWIssue of Equity
24th Jun 202012:35 pmGNWB Share - Extension of Offer
13th May 20203:03 pmGNWPublication of a supplementary prospectus
29th Apr 202012:45 pmGNWIssue of Equity
29th Apr 20207:00 amGNWResult of Annual General Meeting
27th Apr 20206:52 pmGNWUpdate on Omega, Optibiotix and NAVs
20th Apr 20206:36 pmGNWOmega Diagnostics, Net Asset Value, New B Share Pool Investments
7th Apr 20204:35 pmGNWIssue of Supplementary Prospectus
3rd Apr 20202:10 pmGNWIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.